The central insight of the review is structural. Unlike most engineered biomaterials, textiles possess a naturally hierarchical architecture: individual fibers are twisted into yarns, and yarns are interlaced into fabrics through weaving, knitting, or braiding. This nested organization gives textiles a rare combination of tensile strength, porosity, flexibility, and biocompatibility that is difficult to achieve with bulk polymers or rigid implants. A knitted scaffold can deform with a beating heart or a flexing joint while still maintaining the open, interconnected pores that cells need to migrate, proliferate, and form new tissue. It is precisely this marriage of mechanical performance and biological compatibility that the authors identify as the reason textiles can bridge a persistent gap in biomaterial innovation.

The choice of fiber sits at the heart of that performance. The review finds that natural fibers such as silk, collagen, cellulose, and chitosan contribute intrinsic biocompatibility and bioactivity, meaning they can interact favorably with living tissue, supporting cell attachment and even guiding healing processes. Silk fibroin, for example, has long been prized for its strength and slow degradation, while chitosan derived from crustacean shells brings inherent antimicrobial properties. Synthetic polymers, by contrast, offer the opposite virtue: control. Materials such as polyester, polycaprolactone, and polylactic acid allow researchers to tune mechanical stiffness and degradation rates with precision, designing implants that dissolve harmlessly in the body over weeks, months, or years as they are replaced by native tissue. The most promising biomedical textiles, the authors suggest, increasingly blend the two worlds, pairing bioactive natural fibers with robust synthetic ones.

Processing technology is the second pillar of the transformation. Conventional textile techniques such as weaving, knitting, and braiding remain indispensable for load-bearing applications like vascular grafts, hernia meshes, and ligament substitutes, where the anisotropic strength of a woven structure mirrors the mechanics of natural tissue. But the review highlights electrospinning as the technique that has most dramatically expanded the possibilities. By drawing polymer solutions through an electric field, electrospinning produces nanofibers thousands of times thinner than a human hair, creating nonwoven mats that mimic the fibrous extracellular matrix that cells naturally inhabit. These nanofibrous architectures can be loaded with antibiotics, growth factors, or anticancer drugs, turning a simple dressing into a drug-eluting system that releases therapeutic agents exactly where and when they are needed.

The clinical applications mapped in the review span an impressive range. Antimicrobial wound dressings built from chitosan and silver-loaded fibers are already among the most mature technologies, actively fighting infection while maintaining the moist environment that speeds healing. Electroactive scaffolds, which conduct electrical signals to stimulate cell behavior, are being explored for nerve and muscle regeneration, exploiting the fact that many tissues in the body respond to electrical cues. Drug-eluting nanofiber mats offer localized, sustained therapy that reduces systemic side effects. Perhaps most striking is the emergence of biosensing fabrics: textiles embedded with conductive fibers and functional materials that can detect electrophysiological signals such as heart rate, muscle activity, or hydration levels, transforming clothing into continuous, wearable health monitors that require no electrodes or bulky equipment.

This convergence of sensing and therapy points toward what the authors describe as smart functionalities, including piezoelectric fibers that generate small electrical charges when mechanically deformed. A piezoelectric suture or scaffold could, in principle, convert the mechanical energy of body movement into electrical stimulation that promotes tissue growth, blurring the line between passive implant and active therapy. Combined with bioresorbable fibers that safely dissolve once their job is done, such systems could eventually perform their function and then vanish, eliminating the need for removal surgery and reducing long-term complications.

Yet the review is notably candid about the obstacles standing between laboratory promise and clinical reality. Biocompatibility must be demonstrated not just at the material level but across every processing step, including dyes, coatings, and sterilization methods that can introduce cytotoxic residues. Durability is a parallel concern: a textile implant must withstand years of mechanical cycling in the harsh, wet, enzymatically active environment of the body without fraying, degrading unpredictably, or shedding particles. The authors also flag regulatory approval as a significant bottleneck, since textile-based medical devices occupy a complex space between medical devices and pharmaceuticals, particularly when they incorporate drug delivery or sensing electronics. Sustainability adds a further layer of pressure, as the healthcare sector increasingly demands eco-friendly fabrication routes and materials that do not leave a lasting environmental footprint.

Perhaps the most sobering finding in the systematic mapping is how few long-term clinical validations have been reported. The literature between 2014 and 2025 is rich with in vitro studies and animal models, but the authors observe that rigorous, long-term human data remain scarce for many of the most exciting concepts, from electroactive scaffolds to biosensing garments. This gap between publication volume and clinical evidence is a recurring theme in biomaterials research, and the review implicitly serves as a call to action: the field must move beyond proof-of-concept demonstrations toward standardized testing, reproducible manufacturing, and controlled clinical trials if biotextiles are to earn the trust of regulators, physicians, and patients.

The future directions outlined by the team suggest that the next decade of biotextile research will focus on integration rather than invention. Bioresorbable fibers, eco-friendly fabrication methods, and smart functionalities such as piezoelectricity and biosignal detection are identified as the key opportunities, and each of them builds on capabilities that already exist in isolation. The challenge is to combine them into single, coherent platforms: a dressing that senses infection, releases antibiotics in response, and then resorbs; a scaffold that guides regeneration while monitoring the electrical activity of regrowing nerves; a garment that continuously streams physiological data to clinicians without ever needing to be plugged in.

What emerges from this systematic mapping is a picture of a field at an inflection point. The same hierarchical structure that made textiles humanity’s first engineered material, fibers spun and interlaced for warmth and protection, turns out to be almost ideally suited to the demands of modern regenerative medicine. With open-access publication making the analysis freely available to researchers worldwide, and with contributions spanning materials science, biomedical engineering, textile chemistry, and clinical medicine, the review consolidates a decade of evidence into a roadmap. If the challenges of durability, regulation, and clinical validation can be met, the fabric on our backs may soon be indistinguishable in sophistication from the fabric inside our bodies, closing a loop that began when the first bandage was wrapped around the first wound.

Subject of Research: Textile-based biomaterials for wound healing, tissue engineering, drug delivery, and biosensing

Article Title: From clothing to healing: can textiles bridge the gap in biomaterial innovation? A systematic mapping of structure, properties, and biomedical applications

Article References: From clothing to healing: can textiles bridge the gap in biomaterial innovation? A systematic mapping of structure, properties, and biomedical applications. (n.d.). https://doi.org/10.1007/s42114-026-02016-x

Image Credits: AI Generated

DOI: 10.1007/s42114-026-02016-x

Keywords: biotextiles, biomaterials, medical textiles, tissue engineering, drug delivery, electrospinning, nanofibers, biosensors, wearable health monitoring, wound dressings, polycaprolactone, chitosan